Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 13 (6) , 1016-1022.e2
Abstract
No abstract availableKeywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 48 references indexed in Scilit:
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisEuropean Heart Journal, 2013
- Oxidized LDL, LOX-1 and AtherosclerosisCardiovascular Drugs and Therapy, 2011
- Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor‐expressing cells: implications for its therapeutic actionBritish Journal of Pharmacology, 2011
- Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic ReviewPLOS Medicine, 2008
- Effect of Colchicine (0.5 mg Twice Daily) on High-Sensitivity C-Reactive Protein Independent of Aspirin and Atorvastatin in Patients With Stable Coronary Artery DiseaseThe American Journal of Cardiology, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Intestinal Lipoprotein FormationAnnals of Nutrition and Metabolism, 1980
- Role of Microtubules in Lipoprotein Secretion by the LiverNature, 1973